University of California San Francisco

Publications

  1. Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct patterns and potential markers of progression.
    Wang Y, Lih TM, Lee JW, Ohtsuka T, Hozaka Y, Mino-Kenudson M, Adsay NV, Luchini C, Scarpa A, Maker AV, Kim GE, Paulino J, Chen L, Woo J, Jiao L, Sun Z, Goodman D, Pflüger MJ, Roberts NJ, Matthaei H, Goggins MG, Wood LD, Furukawa T, Zhang H, Hruban RH
    Cancer Cell. 2025 Nov 10; 43(11):2156-2170.e6.; 
    PubMed
  2. Prevalence and Size-Based Risk Categorization of Pancreatic Cysts Among Asymptomatic Individuals With Screening MRI.
    Wong P, Pollini T, Hernandez S, Zampese M, Todeschini L, Aguilar LL, Basar SA, Hashemi S, Maker AV
    JAMA Netw Open. 2026 Mar 02; 9(3):e260983.; 
    PubMed
  3. Combination LIGHT overexpression and checkpoint blockade disrupts the tumor immune environment impacting colorectal liver metastases.
    Keenan BP, Qiao G, Kunda N, Kone L, Guldberg SM, Todeschini L, Kumar P, Pollini T, Hernandez S, Qin J, Fong L, Spitzer MH, Prabhakar BS, Maker AV
    Sci Adv. 2025 Oct 10; 11(41):eadv9161.; 
    PubMed
  4. Survival after resection of pancreatic cancer is similar with neoadjuvant gemcitabine-nab-paclitaxel or mFOLFIRINOX but one size will not fit all in the future.
    Hernandez S, Maker AV
    Hepatobiliary Surg Nutr. 2026 Jun 01; 15(3):87.; 
    PubMed
  5. The morbidity of simultaneous pancreatic and liver resection for metastatic pancreatic neuroendocrine tumors.
    Kone LB, Wong P, Jacobs MJ, Maker AV
    J Gastrointest Surg. 2025 10; 29(10):102163.; 
    PubMed
  6. Current Management of Intraductal Papillary Mucinous Neoplasms.
    Pollini T, Wong P, Maker AV
    Hematol Oncol Clin North Am. 2026 02; 40(1):65-77.; 
    PubMed
  7. Minimally Invasive Distal Pancreatectomy as the Standard of Care in the US: Are We There Yet?
    Foroutani L, Gonzalez A, Wang JJ, Aburayya BI, Ganjouei AA, Feng J, Thornblade LW, Hirose K, Maker AV, Nakakura E, Corvera CU, Alseidi A, Adam MA
    Cancers (Basel). 2025 Sep 16; 17(18).; 
    PubMed
  8. Longitudinal tumor-informed ctDNA monitoring for recurrence and treatment response in melanoma.
    Sleeper O, Fortino J, Cho NW, Daud AI, Tsai KK, Lee JC, Alvarado M, Maker AV, Liu L, Kim C, Chan JW
    BMC Cancer. 2026 Apr 02; 26(1).; 
    PubMed
  9. Minimally Invasive Versus Open Resection for Solid Pseudopapillary Tumors of the Pancreas: A Propensity Score-Matched Analysis.
    Wong P, Todeschini L, Pollini T, Hernandez S, Zampese M, Aguilar LL, Peng JS, Thornblade LW, Adam MA, Alseidi A, Corvera CU, Hirose K, Kirkwood KS, Nakakura EK, Maker AV
    J Surg Oncol. 2025 Sep; 132(4):676-683.; 
    PubMed
  10. The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee.
    Coukos G, Donia M, Gastman BR, Goff SL, Gros A, Harari A, Hernandez S, Ito F, Maker AV, Mullinax JE, Murthy P, Pai SI, Prabhakaran S, Restifo NP, Silver NL, Marincola Smith P, Turcotte S, Wagner PL, Yang JC, Lotze MT
    J Immunother Cancer. 2025 Nov 29; 13(11).; 
    PubMed